Search

Your search keyword '"Pharoah, P"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Pharoah, P" Remove constraint Author: "Pharoah, P" Publisher springer nature Remove constraint Publisher: springer nature
42 results on '"Pharoah, P"'

Search Results

1. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

2. Rare germline copy number variants (CNVs) and breast cancer risk

4. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

5. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

6. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

7. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

8. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

9. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

10. Genome-wide association study of germline variants and breast cancer-specific mortality

11. Shared heritability and functional enrichment across six solid cancers

12. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

13. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

14. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.

15. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.

17. Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status.

18. Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.

19. Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer.

20. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript.

21. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.

22. Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer.

23. Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England.

24. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.

25. BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received.

26. Common germ-line polymorphism of C1QA and breast cancer survival.

27. Variation in genes required for normal mitosis and risk of breast cancer.

28. COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.

29. Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival.

30. Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?

31. Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening.

32. HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.

33. Interactions between genes involved in the antioxidant defence system and breast cancer risk.

34. Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population.

35. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.

36. The BOADICEA model of genetic susceptibility to breast and ovarian cancer.

37. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.

38. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis.

41. How to validate a breast cancer prognostic signature.

Catalog

Books, media, physical & digital resources